Abner Herrman & Brock LLC Sells 109 Shares of Thermo Fisher Scientific Inc (NYSE:TMO)

Abner Herrman & Brock LLC cut its stake in shares of Thermo Fisher Scientific Inc (NYSE:TMO) by 0.4% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 25,735 shares of the medical research company’s stock after selling 109 shares during the period. Abner Herrman & Brock LLC’s holdings in Thermo Fisher Scientific were worth $4,490,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Vanguard Group Inc. increased its position in shares of Thermo Fisher Scientific by 2.7% during the first quarter. Vanguard Group Inc. now owns 25,971,301 shares of the medical research company’s stock valued at $3,989,193,000 after buying an additional 695,079 shares during the period. BlackRock Inc. increased its position in shares of Thermo Fisher Scientific by 2,692.1% in the first quarter. BlackRock Inc. now owns 22,988,885 shares of the medical research company’s stock worth $3,531,095,000 after purchasing an additional 22,165,530 shares during the last quarter. State Street Corp increased its position in shares of Thermo Fisher Scientific by 1.0% in the first quarter. State Street Corp now owns 16,085,954 shares of the medical research company’s stock worth $2,470,802,000 after purchasing an additional 164,367 shares during the last quarter. Wellington Management Group LLP increased its position in shares of Thermo Fisher Scientific by 5.6% in the first quarter. Wellington Management Group LLP now owns 7,512,152 shares of the medical research company’s stock worth $1,153,867,000 after purchasing an additional 398,622 shares during the last quarter. Finally, Morgan Stanley increased its position in shares of Thermo Fisher Scientific by 7.6% in the first quarter. Morgan Stanley now owns 4,664,882 shares of the medical research company’s stock worth $716,526,000 after purchasing an additional 327,826 shares during the last quarter. Hedge funds and other institutional investors own 83.52% of the company’s stock.

TRADEMARK VIOLATION WARNING: This piece was first published by BBNS and is the property of of BBNS. If you are viewing this piece on another website, it was stolen and reposted in violation of US and international trademark and copyright legislation. The legal version of this piece can be accessed at https://baseballnewssource.com/markets/abner-herrman-brock-llc-reduces-position-in-thermo-fisher-scientific-inc-tmo/1604393.html.

Shares of Thermo Fisher Scientific Inc (NYSE TMO) traded down 0.07% during trading on Friday, hitting $191.55. The company had a trading volume of 796,273 shares. The company has a market capitalization of $74.73 billion, a P/E ratio of 33.37 and a beta of 1.05. Thermo Fisher Scientific Inc has a 52 week low of $139.07 and a 52 week high of $194.30. The stock’s 50-day moving average price is $179.77 and its 200 day moving average price is $170.30.

Thermo Fisher Scientific (NYSE:TMO) last posted its earnings results on Wednesday, July 26th. The medical research company reported $2.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.27 by $0.03. The company had revenue of $5 billion during the quarter, compared to analysts’ expectations of $4.92 billion. Thermo Fisher Scientific had a return on equity of 15.97% and a net margin of 11.80%. The firm’s quarterly revenue was up 10.2% compared to the same quarter last year. During the same quarter last year, the firm earned $2.03 earnings per share. On average, equities research analysts forecast that Thermo Fisher Scientific Inc will post $9.35 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Monday, October 16th. Shareholders of record on Friday, September 15th will be paid a dividend of $0.15 per share. The ex-dividend date is Thursday, September 14th. This represents a $0.60 annualized dividend and a yield of 0.31%. Thermo Fisher Scientific’s dividend payout ratio (DPR) is 10.45%.

Several research analysts recently weighed in on TMO shares. Zacks Investment Research upgraded shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $199.00 price objective on the stock in a research report on Tuesday, July 11th. Bank of America Corporation restated a “buy” rating and issued a $210.00 price objective (up from $200.00) on shares of Thermo Fisher Scientific in a research report on Friday, July 21st. Cleveland Research upgraded shares of Thermo Fisher Scientific from a “neutral” rating to a “buy” rating in a research report on Thursday, July 20th. Citigroup Inc. restated a “buy” rating and issued a $201.00 price objective (up from $182.00) on shares of Thermo Fisher Scientific in a research report on Monday, July 10th. Finally, BidaskClub cut shares of Thermo Fisher Scientific from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, June 27th. One analyst has rated the stock with a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the stock. Thermo Fisher Scientific presently has an average rating of “Buy” and a consensus price target of $193.56.

In other news, VP Peter E. Hornstra sold 3,894 shares of the firm’s stock in a transaction on Tuesday, September 5th. The stock was sold at an average price of $185.18, for a total transaction of $721,090.92. Following the completion of the transaction, the vice president now directly owns 19,751 shares in the company, valued at $3,657,490.18. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director Jim P. Manzi sold 1,000 shares of the firm’s stock in a transaction on Thursday, August 17th. The stock was sold at an average price of $175.20, for a total value of $175,200.00. Following the transaction, the director now owns 38,757 shares of the company’s stock, valued at $6,790,226.40. The disclosure for this sale can be found here. In the last three months, insiders have sold 22,738 shares of company stock valued at $4,021,512. 0.49% of the stock is owned by insiders.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with our FREE daily email newsletter.

 


Latest News

Young Girl Hit by Foul Ball Rushed to Hospital
Young Girl Hit by Foul Ball Rushed to Hospital
New Home Run Record Reached in Major League Baseball
New Home Run Record Reached in Major League Baseball
Will 2017 MLB Season End with No 20-Game Winner?
Will 2017 MLB Season End with No 20-Game Winner?
Cleveland Indians Winning Streak Snapped at 22
Cleveland Indians Winning Streak Snapped at 22
Tigers Player Might Play All Nine Positions During Same Game
Tigers Player Might Play All Nine Positions During Same Game
Fans Kicked Out of Fenway Park After Racist Banner Hung on Green Monster
Fans Kicked Out of Fenway Park After Racist Banner Hung on Green Monster


Leave a Reply

 
© 2006-2017 BBNS.